CD3 Competitors and Similar CompaniesClear all

CD3's competitors and similar companies include Genentech, Cipla and CSL Behring.
CD3
CD3
CD3 (Centre for Drug Design and Discovery) is an investment fund aimed at promoting the discovery and development of medicines for various kinds of diseases.
Genentech
Genentech
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Cipla
Cipla
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
CSL Behring
CSL Behring
CSL Behring is a provider of life-saving medicines.
Founding Date
Founding Date
2006
Founding Date
1976
Founding Date
1935
Founding Date
1904
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Leuven, BE HQ
Locations
South San Francisco, US HQ
Hillsboro, US
Oceanside, US
Portland, US
South San Francisco, US
South San Francisco, US
South San Francisco, US
see more
Locations
Mumbai, IN HQ
Melbourne, AU
Antwerpen, BE
São Paulo, BR
São Paulo, BR
Unterhaching, DE
Nairobi, KE
see more
Locations
King of Prussia, US HQ
Broadmeadows, AU
Parkville, AU
Parkville, AU
Wien, AT
Mechelen, BE
see more
Employees
Employees
32
Employees
18,077
Employees
27,764
Employees
7,5692% decrease

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
₹277.1b (FY, 2026)
Revenue (est.)
$7.9b (FY, 2020)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
₹195b (FY, 2026)
Gross profit
$4.5b (FY, 2020)
For sources of this data, please see the company profile

View Company Profiles

Genentech
HQ
South San Francisco, US

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.

View company
Cipla
HQ
Mumbai, IN
Employees
27,764

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.

View company
CSL Behring
HQ
King of Prussia, US

CSL Behring is a provider of life-saving medicines.

View company